FDA refuses to review Moderna and #39;s mRNA flu vaccine

12 februarie 2026

The American pharmaceutical company Moderna announced that the United States Food and Drug Administration (FDA) has refused to review the application for authorization for its flu vaccine based on messenger RNA (mRNA) technology, the first of its kind developed by the company, AFP reports.

Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici

Alte articole

Ooni Koda
© Copyright 2023 InfoBursa

Web Design by Dow Media | Gazduire Web by SpeedHost.ro